New biomarkers of ferric management, namely, soluble transferrin receptor (sTfR), growth differentiation factor 15 (GDF15) and hepcidin 25, may correlate with characteristics in the etiology and management of MM-associated anaemia. The gene discussed is GDF15; the disease is Miyoshi myopathy.